Received Mar 19, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RSV | RSV (AREXVY) | GLAXOSMITHKLINE BIOLOGICALS | 2 | — | — |
Extra Dose Administered; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of extra dose administered in a elderly male patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis. Previously administered products included Shingrix (received 1st dose on an unknown date). On an unknown date, the patient received the 2nd dose of Arexvy. On an unknown date, an unknown time after receiving Arexvy, the patient experienced extra dose administered (Verbatim: Extra Dose Administered). The outcome of the extra dose administered was not applicable. Additional Information: GSK Receipt Date: 14-MAR-2025 The pharmacist reported that a patient who was unsure if they got the Arexvy vaccine twice, which led to extra dose administered. So, ask question was if they were vaccinated twice, whether, what should they do. The pharmacist did not have lot number of the vaccines and patient was not sure whether he received the Arexvy vaccine twice. Patient age was approximated by the health care professional between 75-76 years old.